Hereditary xanthinuria

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3467OMIM:278300E79.8
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary xanthinuria is a rare inborn error of purine metabolism characterized by a deficiency of the enzyme xanthine dehydrogenase (also called xanthine oxidase), which is responsible for converting hypoxanthine to xanthine and xanthine to uric acid. This deficiency leads to very low or undetectable levels of uric acid in the blood and urine, with a corresponding accumulation of xanthine and, in some cases, hypoxanthine. There are two main types: Type I (classical xanthinuria), caused by an isolated deficiency of xanthine dehydrogenase due to mutations in the XDH gene, and Type II, caused by a dual deficiency of xanthine dehydrogenase and aldehyde oxidase due to mutations in the MOCOS gene (molybdenum cofactor sulfurase). A third form, molybdenum cofactor deficiency, involves xanthine dehydrogenase deficiency along with sulfite oxidase deficiency and presents with severe neurological impairment. The condition primarily affects the urinary system. Approximately one-third of affected individuals develop xanthine urolithiasis (kidney stones composed of xanthine), which can cause renal colic, hematuria, urinary tract infections, and in severe cases, obstructive uropathy or renal failure. Some patients may also develop xanthine deposits in muscles, leading to myopathy with muscle pain and cramps. However, many individuals with hereditary xanthinuria remain completely asymptomatic throughout life and are diagnosed incidentally through the finding of very low serum uric acid levels (hypouricemia). There is no specific cure for hereditary xanthinuria. Management focuses on prevention of xanthine stone formation through high fluid intake to maintain dilute urine and dietary restriction of purine-rich foods (such as organ meats, certain fish, and legumes) to reduce xanthine production. Allopurinol, which is commonly used for gout, is contraindicated as it inhibits xanthine oxidase and would further increase xanthine accumulation. Prognosis is generally favorable, especially with appropriate preventive measures, and many patients lead normal lives.

Also known as:

Clinical phenotype terms— hover any for plain English:

HypouricemiaHP:0003537Decreased urinary urateHP:0011935Uric acid nephrolithiasisHP:0000791Xanthine nephrolithiasisHP:0000804Aldehyde oxidase deficiencyHP:0002932Reduced xanthine dehydrogenase levelHP:0003534Sulfite oxidase deficiencyHP:0003643HyperxanthinemiaHP:0010933XanthinuriaHP:0010934Increased urinary hypoxanthine levelHP:0011814CrystalluriaHP:0020074ArthropathyHP:0003040Flank painHP:0030157
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary xanthinuria.

View clinical trials →

No actively recruiting trials found for Hereditary xanthinuria at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary xanthinuria community →

Specialists

1 foundView all specialists →

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary xanthinuria.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary xanthinuriaForum →

No community posts yet. Be the first to share your experience with Hereditary xanthinuria.

Start the conversation →

Latest news about Hereditary xanthinuria

No recent news articles for Hereditary xanthinuria.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary xanthinuria

What is Hereditary xanthinuria?

Hereditary xanthinuria is a rare inborn error of purine metabolism characterized by a deficiency of the enzyme xanthine dehydrogenase (also called xanthine oxidase), which is responsible for converting hypoxanthine to xanthine and xanthine to uric acid. This deficiency leads to very low or undetectable levels of uric acid in the blood and urine, with a corresponding accumulation of xanthine and, in some cases, hypoxanthine. There are two main types: Type I (classical xanthinuria), caused by an isolated deficiency of xanthine dehydrogenase due to mutations in the XDH gene, and Type II, caused b

How is Hereditary xanthinuria inherited?

Hereditary xanthinuria follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Hereditary xanthinuria?

1 specialists and care centers treating Hereditary xanthinuria are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.